Bank of America’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Bank of America’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,600	Closed	-$2.95M	–	8032
2023 Q2	$2.95M	Buy	13,600 +8,600	+172%	+$1.84M	﹤0.01%	3862
2023 Q1	$908K	Buy	+5,000	New	+$956K	﹤0.01%	4958
2022 Q3	–	Sell	-4,000	Closed	-$506K	–	8331
2022 Q2	$506K	Buy	+4,000	New	+$460K	﹤0.01%	5422

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Bank of America's KRTX Position: Q1 2024 in Review

Bank of America sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 110,962 shares — an estimated $35.1M sold.

Bank of America first reported a position in KRTX in Q2 2019 and held it in 19 quarters. The position peaked at $42.2M in Q1 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Bank of America reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Bank of America sold 110,962 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $35.1M.
Bank of America first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2019 and held it in 19 quarters.
Bank of America's Karuna Therapeutics, Inc. Common Stock position peaked at $42.2M in Q1 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Bank of America's 13F filing for Q1 2024, filed 15 May 2024.